Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
Elena J. Orlando, Wendy Winckler(Unknown), Michael R. Verneris(NHS Blood and Transplant), Hidefumi Hiramatsu(Kyoto University), Piotr Pierog(Novartis (United States)), Rebecca Leary(Howard Hughes Medical Institute), Stella M. Davies(Cincinnati Children's Hospital Medical Center), Catherine Tribouley, Eneida R. Nemecek(Oregon Health & Science University), Muna Qayed(Emory University), Jochen Buechner(Oslo University Hospital), Jeffrey A. Engelman(Cancer Research Center), John E. Levine(Icahn School of Medicine at Mount Sinai), Serafino Pantano(Novartis (Switzerland)), Michael Morrissey(Novartis (United States)), Markus Riester(Harvard University), Barbara De Moerloose(Ghent University Hospital), Michael Boyer(Chris O’Brien Lifehouse), Stephan A. Grupp(Children's Hospital of Philadelphia), Henrique Bittencourt(Centre Hospitalier Universitaire Sainte-Justine), Xia Han(Mechanical Solutions (United States)), Kevin T. Nguyen(Navidea Biopharmaceuticals (United States)), Hans Bitter, Patricia A. Wood(Albany Stratton VA Medical Center Albany), Jennifer L. Brogdon
Cited by 577
Related Papers
Integrative genomics viewer
|Nature Biotechnology|2011|16.5k
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
|Science|2015|5.7k
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k